32 results
424B3
PROK
ProKidney Corp - Ordinary Shares
22 Aug 23
Prospectus supplement
7:13pm
and sole investment power with respect to all securities that they beneficially own, subject to community property laws where applicable.
Selling
POS AM
PROK
ProKidney Corp - Ordinary Shares
18 Aug 23
Prospectus update (post-effective amendment)
4:07pm
that they beneficially own, subject to community property laws where applicable.
Selling Securityholder information for each additional Selling Securityholder
DEF 14A
PROK
ProKidney Corp - Ordinary Shares
26 May 23
Definitive proxy
8:00am
that are currently exercisable or exercisable within 60 days. Except as described in the footnotes below and subject to applicable community property
424B3
4ai3echw3o9p5pik
21 Apr 23
Prospectus supplement
4:18pm
POS AM
dcupjqdmpmxwm
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
8-K
EX-99.1
z3pnssz
14 Nov 22
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10:34am
424B3
jg97b5m1upbm1
9 Sep 22
Prospectus supplement
5:05pm
DEFM14A
6tnybm yrydyg9ai37
10 Jun 22
Proxy related to merger
4:54pm
DEFA14A
1wph8xwn8c7
8 Jun 22
Additional proxy soliciting materials
4:31pm
DEFA14A
ifdete1z4snkuad4ho
26 May 22
Additional proxy soliciting materials
4:37pm
DEFA14A
pnq2a
11 May 22
Additional proxy soliciting materials
4:55pm
PRER14A
e4wjqenxklxw4
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
0k5rx16j402g 92
23 Mar 22
Annual report
5:32pm